At Loy & Co, Fabian Raschke brings the perspective of an active CFO in M&A transactions and capital market-oriented corporate finance within the life sciences and industrial sectors.
As a member of the Group Executive Board at Grünenthal, he is responsible for the global finance and IT organisation of an internationally operating pharmaceutical company.
His expertise covers M&A, complex integrations and capital market-oriented financing structures, ranging from IPO preparation to bond issues.